Nonprofit Kidney Care Alliance

Nonprofit organization representing nonprofit dialysis facilities

Based in DC

🤖

AI Overview

With $2.5M in lobbying spend across 29 quarterly filings, Nonprofit Kidney Care Alliance is a significant lobbying presence.

$2.5M
Total Lobbying Spend
29
Quarterly Filings
1
Lobbying Firms Used
4
Individual Lobbyists

Spending by Year

YearLobbying Spend
2018$320K
2019$320K
2020$360K
2021$360K
2022$250K
2023$360K
2024$180K
2025$360K

Lobbying Firms

HOOPER, LUNDY & BOOKMAN, P.C.

What They Lobby For

  • End-stage renal disease (ESRD) rebasing, Medicare reimbursement, and payment reform. Center for Medicare and Medicaid Innovation (CMMI)Comprehensive ESRD Care Initiative. Improved policies for chronic kidney disease (CKD). Improved policies for transplantation. Implementation of the Medicare Access and CHIP Reauthorization Act (MACRA). Medicare Third Party Payment. Living Donor Protection Act (H.R. 1270). The Dialysis PATIENTS Demonstration Act (H.R. 4143/S. 2065). MA risk adjustment for CKD.
  • End-stage renal disease (ESRD) rebasing, Medicare reimbursement, and payment reform. Center for Medicare and Medicaid Innovation (CMMI)Comprehensive ESRD Care Initiative (CEC). Improved policies for chronic kidney disease (CKD). Improved policies for transplantation. Implementation of the Medicare Access and CHIP Reauthorization Act (MACRA). Medicare Third Party Payment. Living Donor Protection Act (H.R. 1270). The Dialysis PATIENTS Demonstration Act (H.R. 4143/S. 2065). MA risk adjustment for CKD. Changes to the Comprehensive ESRD Care Model.
  • Kidney X Funding Request.
  • Living Donor Protection Act (HR 1224/S. 511).
  • Centers for Medicare and Medicaid Innovation(CMMI)Comprehensive ESRD care model and future payment models; Improving policies on chronic kidney disease and transplantation.
  • Kidney X Funding Request; Centers for Medicare and Medicaid Innovation(CMMI)Comprehensive ESRD care model and future payment models; Improving policies on chronic kidney disease and transplantation.
  • Kidney X Funding Request; Centers for Medicare and Medicaid Innovation(CMMI)Comprehensive ESRD care model and future payment models; Improving policies on chronic kidney disease and transplantation; Legislation impacting organ procurement organizations; 2020 hospice proposed rule; Provisions related to alternative payment models; Improving end of life, hospice, and palliative care option for those with ESRD.
  • Centers for Medicare and Medicaid Innovation(CMMI)Comprehensive ESRD care model and future payment models; Improving policies on chronic kidney disease and transplantation; Legislation impacting organ procurement organizations; 2020 hospice proposed rule; Provisions related to alternative payment models; Improving end of life, hospice, and palliative care option for those with ESRD; ESRD Treatment Choices Model Implementation; Kidney Care Models through CMMI.
  • Centers for Medicare and Medicaid Innovation (CMMI) models including, Comprehensive ESRD care, ESRD Treatment Choices, and voluntary Kidney Care models, Improving policies on chronic kidney disease and transplantation, Improving end of life, hospice, and palliative care options for individuals with ESRD, Policies impacting Organ Procurement Organizations, COVID-19 policies and relief.
  • Centers for Medicare and Medicaid Innovation (CMMI) models including, Comprehensive ESRD care, ESRD Treatment Choices, and voluntary Kidney Care models, Improving policies on chronic kidney disease and transplantation, Improving end of life, hospice, and palliative care options for individuals with ESRD, Policies impacting Organ Procurement Organizations, COVID-19 policies and relief, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act (H.R. 5534/S.3353), Policies related to the implementation of ESRD coverage in Medicare Advantage.

Related Investigations

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.